Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
October 04, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
MDT
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
October 04, 2024
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
ABBV
BGNE
ELVN
HCM
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
October 04, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AZN
MRK
NVO
SNY
IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
October 01, 2024
Via
PRLog
Topics
Artificial Intelligence
Intellectual Property
Regulatory Compliance
Exposures
Artificial Intelligence
Intellectual Property
Legal
Tickers
IGC
Stellantis Recalls More Than 129K Ram 1500 Trucks
October 04, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
October 04, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
Philips Issues Software Fix For Some Ventilators To Fix Power Alarms Issues, Oxygen Display Errors
October 03, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
PHG
AstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority Review
October 03, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AZN
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in Upcoming Water Tower Research Fireside Chat
October 03, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
ASX:TWR
CYBN
Tesla Recalls 27,185 Cybertruck Vehicles Over Rearview Camera Delay
October 03, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
Dr. Gianluca Cerri MD Advocates for Improved Training and Mentorship for Future Emergency Medicine Physicians
October 02, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Mark Cuban Says 'I Was Broke, Fat, But Having Fun' – Recalls Sleeping On The Floor And Gaining 50 Pounds From Eating Free Food
October 02, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M
October 02, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Psilocybin's Potentially Revolutionary Ability To Treat Depression Hinges On FDA Approval – AJNA BioSciences Is Standardizing Raw Materials To Meet Guidelines
October 02, 2024
Via
News Direct
Exposures
Product Safety
Tickers
SDZNY
Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors'
October 01, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GRTS
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Featured in Post Discussing Nonaddictive Painkillers Designed to Counter Opioid Crisis
October 01, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
Stellantis Recalls Over 154K Jeep Plug-Hybrid SUVs In US Citing Fire Risk
October 01, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
September 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SPRC
George J. Priester Aviation brings generations of luxury to customers through personalized, private aviation that makes travel easy, efficient, and memorable
September 30, 2024
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Coal
Legal
Product Safety
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
September 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AQST
INCY
LLY
PFE
BridgeBio Pharma's Lead Candidate Cuts Mortality, Related Hospitalizations In Patients With Certain Type Of Heart Disease
September 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BBIO
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins Expert Panel at Long COVID, RECOVER TLC Workshop
September 30, 2024
Via
Investor Brand Network
Exposures
COVID-19
Product Safety
Tickers
TNXP
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
September 30, 2024
Via
MarketBeat
Exposures
Product Safety
Tickers
CAPR
PEPG
SRPT
BYD Recalls Nearly 97K EVs Over Concerns Of Overheating Part, Potential Fire
September 30, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
BYDDF
BYDDY
Why Investors Slammed the Brakes on Toyota Stock Today
September 27, 2024
Via
The Motley Fool
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TM
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ABBV
BMY
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
September 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMEA
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
September 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
REGN
SNY
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) Receives New US Patent for Subcutaneous Administration of Zembrace(R) SymTouch(R) to Treat Migraines
September 27, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
TNXP
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
September 27, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
REGN
SNY
VRNA
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.